Identification of small molecule glucokinase activators for the treatment of diabetes based on plants from the traditional Chinese medicine: In silico analysis
Microbial Pathogenesis · 2024
DOI: 10.1016/j.micpath.2024.106851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2024. Verfasst von Jihane Khamlich und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Biochemistry Environment and Agri-food, Department of Biology, Faculty of Science and Technics Mohammedia, Hassan II University Casablanca…. Hauptthemen laut MEDLINE: Glucokinase, Molecular Docking Simulation, Molecular Dynamics Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Mutations in glucokinase (GCK) can either enhance or inhibit insulin secretion, leading to different forms of diabetes, including gestational diabetes. While many glucokinase activators (GKAs) have been explored as treatments, their long-term effectiveness has often been unsatisfactory. However, recent interest has surged with the introduction of dorzagliatin and TTP399. This study investigates the efficacy of four previously studied compounds (Swertiamarin, Apigenin, Mangiferin, and Tatanan A) in activating GCK using computational methods. Initial molecular docking revealed binding affinities ranging from -6.7 to -8.6 kcal/mol. The compounds were then evaluated for drug-likeness and pharmacokinetic properties. Re-docking studies were performed for validation. Based on their favorable binding affinities and compliance with Lipinski's rule and ADMET criteria, three compounds (Swertiamarin, Apigenin, and Tatanan A) were selected for molecular dynamics (MD) simulations. MD simulations demonstrated that Swertiamarin showed excellent stability, as indicated by analyses of RMSD, RMSF, radius of gyration (Rg), hydrogen bonding, and principal component analysis (PCA). These results suggest that Swertiamarin holds promise for further investigation in in vivo and clinical settings to evaluate its potential in enhancing GCK activity and treating diabetes. This study assessed the potential of four compounds as GCK activators using molecular docking, pharmacokinetic profiling, and MD simulations. Swertiamarin, in particular, showed significant stability and adherence to drug-likeness criteria, making it a promising candidate for further research in combating diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Biochemistry Environment and Agri-food, Department of Biology, Faculty of Science and Technics Mohammedia, Hassan II University Casablanca, Morocco; Laboratory of Biology and Health, URAC 34, Faculty of Scien…
- Laboratory of Biology and Health, URAC 34, Faculty of Sciences Ben M'Sik Hassan II University of Casablanca, Morocco. Electronic address: asmae.saih-etu@etu.univh2c.ma.
- Laboratory of Immunology and Biodiversity, Faculty of Sciences Ain chock, Hassan II University of Casablanca, Morocco. Electronic address: samyamoussamih@yahoo.fr.
- Faculty of Medicine and Pharmacy Casablanca (FMPC), Hassan II University, Morocco. Electronic address: as.regragui21@gmail.com.
- Laboratory of Biology and Health, URAC 34, Faculty of Sciences Ben M'Sik Hassan II University of Casablanca, Morocco; Mohammed VI Center for Research & Innovation, Rabat, Morocco & Mohammed VI University of Health Scien…
- Laboratory Biochemistry Environment and Agri-food, Department of Biology, Faculty of Science and Technics Mohammedia, Hassan II University Casablanca, Morocco. Electronic address: amal.safi@fstm.ac.ma.
Zitieren
APA
Khamlich, J., Douiyeh, I., Saih, A., Moussamih, S., Regragui, A., Kettani, A., & Safi, A. (2024). Identification of small molecule glucokinase activators for the treatment of diabetes based on plants from the traditional Chinese medicine: In silico analysis. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2024.106851
Vancouver
Khamlich J, Douiyeh I, Saih A, Moussamih S, Regragui A, Kettani A, et al. Identification of small molecule glucokinase activators for the treatment of diabetes based on plants from the traditional Chinese medicine: In silico analysis. Microbial Pathogenesis. 2024. doi:10.1016/j.micpath.2024.106851
BibTeX
@article{Khamlich2024,
author = {Khamlich, Jihane and Douiyeh, Imane and Saih, Asmae and Moussamih, Samya and Regragui, Anas and Kettani, Anass and Safi, Amal},
title = {Identification of small molecule glucokinase activators for the treatment of diabetes based on plants from the traditional Chinese medicine: In silico analysis},
journal = {Microbial Pathogenesis},
year = {2024},
doi = {10.1016/j.micpath.2024.106851}
}
EUVIMED